- Home
- NXC vs CVM Comparison
NXC vs CVM Comparison
Compare NXC & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXC
- CVM
- Stock Information
- Founded
- NXC 1992
- CVM 1983
- Country
- NXC United States
- CVM United States
- Employees
- NXC N/A
- CVM N/A
- Industry
- NXC Investment Managers
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NXC Finance
- CVM Health Care
- Exchange
- NXC Nasdaq
- CVM Nasdaq
- Market Cap
- NXC 83.5M
- CVM 71.2M
- IPO Year
- NXC N/A
- CVM 1987
- Fundamental
- Price
- NXC $12.95
- CVM $10.03
- Analyst Decision
- NXC
- CVM
- Analyst Count
- NXC 0
- CVM 0
- Target Price
- NXC N/A
- CVM N/A
- AVG Volume (30 Days)
- NXC 17.5K
- CVM 303.9K
- Earning Date
- NXC 01-01-0001
- CVM 08-14-2025
- Dividend Yield
- NXC 3.97%
- CVM N/A
- EPS Growth
- NXC N/A
- CVM N/A
- EPS
- NXC 0.19
- CVM N/A
- Revenue
- NXC N/A
- CVM N/A
- Revenue This Year
- NXC N/A
- CVM N/A
- Revenue Next Year
- NXC N/A
- CVM N/A
- P/E Ratio
- NXC $70.47
- CVM N/A
- Revenue Growth
- NXC N/A
- CVM N/A
- 52 Week Low
- NXC $11.86
- CVM $1.98
- 52 Week High
- NXC $13.70
- CVM $39.30
- Technical
- Relative Strength Index (RSI)
- NXC 56.45
- CVM 52.57
- Support Level
- NXC $12.88
- CVM $9.58
- Resistance Level
- NXC $13.05
- CVM $12.68
- Average True Range (ATR)
- NXC 0.10
- CVM 1.30
- MACD
- NXC 0.02
- CVM -0.28
- Stochastic Oscillator
- NXC 69.12
- CVM 28.57
About NXC Nuveen California Select Tax-Free Income Portfolio
Nuveen CA Select Tax Free Income Port is a diversified closed-end management investment company. Its objective is to provide stable dividends exempt from both regular federal and California income taxes, consistent with the preservation of capital by investing in municipal obligations.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.